Clinical trial
Anterior Bridge-Preserving Semi Circular Early Apical Release Versus Conventional Early Apical Release During HoLEP: A Prospective Randomized Comparative Study
NCT07892599 is registered in ClinicalTrials.gov with Ahmed Ebrahim Zahran as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anterior Bridge-Preserving Semi Circular Early Apical Release Versus Conventional Early Apical Release During HoLEP: A Prospective Randomized Comparative Study
- Lead sponsor
- Ahmed Ebrahim Zahran
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- April 30, 2029
- Enrollment
- 230 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
benign prostatic hyperplasia, benign prostatic obstruction, lower urinary tract symptoms (luts) in men with benign prostatic hyperplasia (bph), stress urinary incontinence
Arms
As registered; 2 arms.
-
ABP-S-EAR HoLEP
Holmium laser enucleation of the prostate with Anterior Bridge-Preserving Semicircular Early Apical Release. Semicircular apical mucosal incisions run from 6 o'clock to 11 o'clock (right) and to 1 o'clock (left). The anterior apical tissue bridge between 11 and 1 o'clock is left intact. Retrograde enucleation and intravesical morcellation follow.
-
Conventional EAR HoLEP
Holmium laser enucleation of the prostate with conventional early apical release. A continuous circumferential apical mucosal incision through the 12 o'clock position divides the anterior mucosal bridge. Retrograde enucleation and intravesical morcellation follow.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Proportion of Participants With Objective Urinary Continence at 1 Month
Continence defined as zero pad use with no urge incontinence, confirmed by a standardized 1-hour pad test with pad weight gain of 1 g or less. Assessed by a masked outcome assessor
Similar trials
Same condition (Urinary Incontinence, Stress) and phase, most recent start first.
+384 more trials See the condition page